key: cord-0708982-5lkj523j
authors: Sano, Motoaki; Shirakawa, Kohsuke; Katsumata, Yoshinori; Ichihara, Genki; Kobayashi, Eiji
title: Low-Flow Nasal Cannula Hydrogen Therapy
date: 2020-09-21
journal: J Clin Med Res
DOI: 10.14740/jocmr4323
sha: 28100f4c0089494aab065c676c0463e5659f2661
doc_id: 708982
cord_uid: 5lkj523j

BACKGROUND: Molecular hydrogen (H(2)) is a biologically active gas that is widely used in the healthcare sector. In recent years, on-site H(2) gas generators, which produce high-purity H(2) by water electrolysis, have begun to be introduced in hospitals, clinics, beauty salons, and fitness clubs because of their ease of use. In general, these generators produce H(2) at a low-flow rate, so physicians are concerned that an effective blood concentration of H(2) may not be ensured when the gas is delivered through a nasal cannula. Therefore, this study aimed to evaluate blood concentrations of H(2) delivered from an H(2) gas generator via a nasal cannula. METHODS: We administered 100% H(2), produced by an H(2) gas generator, at a low-flow rate of 250 mL/min via a nasal cannula to three spontaneously breathing micro miniature pigs. An oxygen mask was placed over the nasal cannula to administer oxygen while minimizing H(2) leakage, and a catheter was inserted into the carotid artery to monitor the arterial blood H(2) concentration. RESULTS: During the first hour of H(2) inhalation, the mean (standard error (SE)) H(2) concentrations and saturations in the arterial blood of the three pigs were 1,560 (413) nL/mL and 8.85% (2.34%); 1,190 (102) nL/mL and 6.74% (0.58%); and 1,740 (181) nL/mL and 9.88% (1.03%), respectively. These values are comparable to the concentration one would expect if 100% of the H(2) released from the H(2) gas generator is taken up by the body. CONCLUSIONS: Inhalation of 100% H(2) produced by an H(2) gas generator, even at low-flow rates, can increase blood H(2) concentrations to levels that previous non-clinical and clinical studies demonstrated to be therapeutically effective. The combination of a nasal cannula and an oxygen mask is a convenient way to reduce H(2) leakage while maintaining oxygenation.

Molecular hydrogen (H 2 ) has a wide range of benefits, ranging from improving health to preventing and treating disease. The health benefits include improving mood, reducing anxiety, and counteracting an overactive sympathetic nervous system [1] . In terms of disease prevention and treatment, H 2 has been used to treat many diseases, including lifestyle diseases [2] ; immune diseases, such as atopic dermatitis [2] , hay fever [3] , and chronic rheumatoid arthritis [4] ; respiratory diseases, such as asthma [5] , chronic obstructive pulmonary disease [6] , and pneumonia caused by the coronavirus disease 2019 (COV-ID-19) [7] ; neurological diseases, such as depression [8] , dementia [9] , stroke [10] , post-cardiac arrest syndrome [11, 12] , subarachnoid hemorrhage [13] , and traumatic injury from blast shock waves [14] ; myocardial infarction [15] [16] [17] ; chronic kidney disease [18] ; sepsis [19] and hemorrhagic shock [20, 21] ; and cancer [22] . H 2 exerts antioxidant and anti-inflammatory effects. As a molecular mechanism, ex vivo experiments have been shown that H 2 reduces hydroxyl radical (·OH) and peroxynitrite [10] and suppresses the propagation of the radical reaction in lipid bilayers [23] . Clinical and animal studies have shown that H 2 therapy reduces circulating levels of oxidative stress markers and proinflammatory cytokines in shock from a wide range of etiologies [11, 24] . H 2 can be supplied from a high-pressure gas cylinder [11, 12, [15] [16] [17] , generated from a hydrogen-absorbing alloy [25, 26] or hydride, or produced by electrolysis of water [7] . In recent years, on-site H 2 gas generators, which generate highpurity H 2 by electrolysis of water, have begun to be introduced in hospitals, clinics, beauty salons, and fitness clubs because of their ease of handling.

Recently, the results of a clinical study on the therapeutic effect of H 2 inhalation in COVID-19 pneumonia were reported from China [7] . In this study, the researchers used an H 2 gas generator as the source of H 2 and administered a mixture of H 2 and oxygen (O 2 ) gas (66% H 2 ; 33% O 2 ), obtained by electrolysis of water, by a nasal cannula. An improvement in clinical symptoms was seen in a significantly higher percentage of patients in the treatment group, who inhaled a mixture of H 2 and Because the H 2 produced from an on-site H 2 gas generator has a low-flow rate, clinicians are concerned that when H 2 is inhaled through a nasal cannula, blood concentrations may be lower than expected because of leakage of H 2 from the nostrils. We hypothesized that the H 2 concentration could be better ensured if patients wore an oxygen mask over the nasal cannula. Therefore, we tested this hypothesis in pigs, whose organs are similar in size, anatomy, and physiology to those of humans.

The present study was designed according to the principles of the ARRIVE (Animal Research: Reporting of In Vivo Experiments) guidelines [27] . The experiments were performed in accordance with our institutional guidelines and with the Japanese law on the protection and management of animals. Ethical approval was granted by the Research Council and Animal Care and Use Committee of Keio University (approval no: 12094-(8)).

The study was performed in three micro miniature pigs, weighing 16.8 kg, 15.5 kg, and 16.8 kg, which were housed in separate cages under temperature-and light-controlled conditions (12-h light/dark cycle) and provided with food and water ad libitum (Supplementary Material 1, www.jocmr.org). Before surgery, the pigs were fasted for 12 h, with free access to water. Then, a xylazine hydrochloride intramuscular injection was given 15 min before induction of isoflurane anesthesia. Experiments were performed under anesthesia, and isoflurane was administered to maintain immobilization.

First, a central venous catheter (14 gauge × 70 cm; Argyle) equipped with a three-way stopcock (TERUMO terufusion three-way stopcock, R type) was filled with heparinized saline. Once at a sufficient depth of anesthesia, each pig was placed in the supine position. A vertical incision of about 10 cm was made in the right side of the neck to expose about 3 cm of the right external jugular vein and the right internal carotid artery. The peripheral side of the right internal carotid artery was ligated with a 1-0 silk thread, a bulldog clip was applied to the medial side, an incision was made, and a catheter was advanced about 5 cm into the artery and secured. Surgery was performed by the senior author of this paper (EK), a surgeon who has completed more than 200 clinical transplant operations and is a steering member of the transplantation society and a permanent director of the transplantation society of Japan. Blood was collected from the intravascular catheters at 0, 10, 30, and 60 min after starting H 2 inhalation, and the blood H 2 concentration was measured by gas chromatography.

This study used the H 2 inhaler H2JI1, manufactured by Doctors Man Co, Ltd. The inhaler uses a proton-exchange membrane (PEM) water electrolysis system that can continuously generate high purity (> 99.999%) H 2 at a flow rate of 250 mL/ min, 24 h a day, 365 days a year (Supplementary Material 2, www.jocmr.org).

The length of the part of the nasal cannula (Nakamura Medical Industry Co., Ltd.) that is inserted into the nostrils was modified from the original 12 mm to 62 mm by inserting a 10-mm silicon tube with a total length of 60 mm, an outer diameter of 3 mm, and an inner diameter of 1.5 mm into the left and right outlets. We then adjusted the nostril inserts of the nasal cannula to fit the shape of a pig's nose. The nasal cannula was inserted deep into the nasal cavity of a pig under spontaneous breathing, and 100% H 2 produced from the H 2 gas generator was administered at a flow rate of 250 mL/min ( Fig. 1) .

A veterinary anesthesia mask (Shinano Manufacturing Co., Ltd.) was placed over the nasal cannula and an ADS 1000 (model: 2000) veterinary anesthesia delivery system (Tokushima Iryoki Co., Ltd.) was used to deliver a mixture of O 2 and isoflurane (Fig. 2) . The flow rate of the O 2 /isoflurane gas mixture was maintained above 6 L/min to avoid re-inhalation of exhaled carbon dioxide (CO 2 ) that would stay in the mask.

To measure the blood H 2 concentration, we first inserted a needle into the rubber lid of a 13.5-mL sealed vial, extracted 1 mL of air and injected 1 mL of blood. To prevent outgassing, we immediately applied wax to the rubber lid to seal the injection hole. H 2 in the blood was released into the air phase in the closed vial. Some of the air phase (0.2 mL, 0.4 mL, or 1 mL, depending on the H 2 concentration) was collected from the vial, and the H 2 concentration was measured by gas chromatography (TRIlyzer mBA-3000, Taiyo, Co., Ltd.). A calibration curve was obtained by using standard H 2 gas of 0, 5, 50, and 130 ppm. Each sample was measured twice. The concentration of the sample taken before H 2 inhalation was subtracted as the background [26] .

In all three pigs, the blood H 2 concentrations in the carotid arteries before inhalation were almost 0, reached peak levels by 10 min after the start of inhalation and remained at approximately the same level until 60 min later. The means (standard error (SE)) of the H 2 concentrations and saturations in the blood from the carotid arteries during H 2 inhalation in the three pigs were 1,560 (413) nL/mL and 8.85% (2.34%); 1,190 (102) nL/mL and 6.74% (0.58%); and 1,740 (181 nL/mL) and 9.88% Low-Flow Hydrogen Therapy J Clin Med Res. 2020;12(10):674-680

(1.03%), respectively ( Fig. 3 and Supplementary Material 3, www.jocmr.org).

We calculated the fraction of inspiratory H 2 from the H 2 flow rate produced by the H 2 gas generator, as follows: The H 2 flow rate per second was 250/60 mL, so at a respiratory rate of 20 breaths per minute, the expected volume of H 2 that would accumulate in the nasopharynx during 3-s inhalation time and exhalation was 250/60 mL × 3 = 12.5 mL. If H 2 was inhaled without leakage from the nostrils, the fraction of inspiratory H 2 would be 12.5/150 = 0.083, or 8.3% at a tidal volume of 150 mL. In short, the measured H 2 concentration (saturation) in the arterial blood agreed closely with the expected value predicted from the H 2 gas generator's flow rate.

In this experiment to establish a methodology for efficiently delivering 100% H 2 with an on-site H 2 gas generator, we administered H 2 to three pigs through a nasal cannula with an oxygen mask worn over it. Our study showed that an effective blood H 2 concentration can be achieved even with the lowflow rates of the H 2 gas generator.

The H2JI1 H 2 gas generator used in this study consistently supplies 100% H 2 with a purity greater than 99.999% at a flow rate of 250 mL/min. If such a generator is used to administer H 2 to a human, at a tidal volume of 500 mL and 20 breaths per minute the expected inspired H 2 concentration would be 2.5%. This concentration would be even higher in the elderly, who have a lower tidal volume. . Nasal cannula and oxygen mask for micro miniature pigs. The length of the part of the nasal cannula that is inserted into the nostrils was modified from the original 12 mm to 62 mm by inserting a 10-mm silicon tube. The nasal cannula was then inserted deep into the nasal cavity of a spontaneously breathing pig, and 100% H 2 produced by the H 2 gas generator was administered at a flow rate of 250 mL/min. A veterinary anesthesia mask was placed over the nasal cannula, and a veterinary anesthesia delivery system was used to supply oxygen and anesthesia to the animals.

Low-Flow Hydrogen Therapy J Clin Med Res. 2020;12(10):674-680

In our previous clinical study to evaluate the safety and efficacy of H 2 inhalation in patients with ST-segment elevation myocardial infarction [17] , we delivered H 2 via high-pressure compressed gas cylinders containing a mixture of H 2 (1.3%), O 2 , nitrogen, and mixed gases through a mask at a high-flow rate of 10 L/min. We chose this flow rate to ensure that the concentration of inhaled H 2 was 1.3% because this concentration was confirmed to be effective in reducing infarct size in preclinical studies in dogs [16] . The High-Pressure Gas Safety Act stipulates that when O 2 and H 2 are mixed under pressure, the H 2 concentration must be no greater than 1.3%. In the present study, we found that even though the flow of 100% H 2 generated on site by the H 2 gas generator was low, if H 2 was administered by a nasal cannula covered with an oxygen mask the arterial blood H 2 saturation levels increased to the same levels as when high-flow 1.3% H 2 was administered from compressed gas high-pressure cylinders.

The H 2 gas generator is lightweight and portable and can provide H 2 anywhere, as long as a power source and pure water are available. Furthermore, the generator can supply H 2 continuously for a long time. The generator represents a safe and convenient alternative to high-pressure gas cylinders for H 2 inhalation therapy and requires no replenishment of supplies. For example, installing an H 2 gas generator at the bedside of a patient with COVID-19 pneumonia with hypoxemia allows the patient to consistently inhale H 2 through a nasal cannula. In addition, a suitable mask (face mask, face mask with reservoir, or Venturi mask) can be worn over the nasal cannula, depending on the patient's level of oxygenation. Using this method, a patient can continuously inhale H 2 until the pneumonia is cured and the patient is discharged from the hospital. Similarly, patients with mild cases of COVID-19 who are waiting outside a hospital can be given H 2 inhalation to prevent their illness becoming more severe.

Although some people experience a headache after inhaling H 2 , probably due to the dilatation of intracranial blood vessels, no other obvious symptoms are known that could be considered adverse events. Unlike the other bioactive gases, such as nitric oxide (NO), carbon monoxide (CO), and hydrogen sulfide (H 2 S), H 2 does not bind to the heme in the hemoglobin in the red blood cells. Therefore, the O 2 saturation and the partial pressures of O 2 and CO 2 in arterial blood are unaffected by the inhalation of H 2 under steady-state conditions [15] .

H 2 is the most abundant element in the universe, but it must be produced because it does not occur naturally in a gaseous state on Earth. H 2 has been used in laboratories for a variety of applications, including gas chromatography and inductively coupled plasma-mass spectrometry. In addition, it is used in the chemical industry to synthesize ammonia, cyclohexane, and methanol, and in the food industry to hydrogenate oils to make them more solid. Recently, it has been gaining attention as a clean energy source. The best way to produce high-purity H 2 on demand is by electrolysis of water. A noteworthy innovation in this technology was water electrolysis with solid polymer electrolyte membranes proposed by General Electric in the early 1970s. Subsequent significant research and development led to a technology for efficiently and stably generating high-purity H 2 from pure water 24 h a day, 365 days a year. This method for generating H 2 , which has been cultivated by the industry for a long time, has found many uses in humans. The H 2 gas generator H2JI1 that we used in our experiments also uses a polymer electrolyte membrane with a durability of more than 50,000 h. The amount of H 2 that remains in this device is small, so safety is guaranteed. Also, the device is not subject to the High-Pressure Gas Safety Act. Although the hydrogen gas generator itself is expensive, the durability of the electrolytic cells is long and the running costs are almost zero. Therefore, the cost per hour is as low as less than $0.47.

Of course, both high-pressure gas cylinders and H 2 gas generators must be used appropriately, depending on a patient's situation. When administering H 2 via a ventilator, physicians should choose high-pressure gas cylinders capable of delivering high-flow rates of gas. However, if physicians wish to administer H 2 continuously over a long period of time to patients who are breathing spontaneously, we propose that they should consider using a H 2 gas generator that can safely produce low-flow but 100% H 2 on-site.

Not much time has passed since O 2 inhalation began to be used in medical settings. First, O 2 was widely used in industries such as welding and cutting because it supports combustion, but during 1918 -1920 physicians starting using O 2 to treat the "Spanish flu." Citizens rushed to industrial O 2 supply companies and queued all night waiting for O 2 to arrive. In light of the current COVID-19 pandemic, we propose that now is the time to reconsider the benefits of H 2 inhalation therapy. the following patents/patent applications associated with this research: Author MS is the registered inventor of the following patents jointly filed by Keio University and Taiyo Nippon Sanso: hydrogen mixed gas supply device for medical purposes (patent number: 5631524), medicinal composition for improving prognosis after restart of patient's own heartbeat, and medicinal composition for improving and/or stabilizing circulatory dynamics after onset of hemorrhagic shock. In addition to these, there are three other patents in which the name of the inventions are only in Japanese and not described in English. Here are the names of the inventions, which are literal translation of Japanese into English: pharmaceutical compositions for reducing weight loss after organ harvesting (Joint application with Keio University and Taiyo Nippon Sanso), method for generating organ preservation solution containing hydrogen and organ preservation solution containing hydrogen (Joint application with Keio University and Doctors Man; Application number PCT/JP2019/045790). This does not alter our adherence to Journal of Clinical Medicine Research policies on sharing data and materials.

Not applicable.

MS designed the study, oversaw data collection, reviewed the literature, analyzed and interpreted the data, and drafted the manuscript. EK contributed to the design of the study, engaged in data collection and provided critical reviews of the manuscript. KS, YK, and GI contributed to data collection and provided critical reviews of the manuscript.

Hydrogen-rich water for improvements of mood, anxiety, and autonomic nerve function in daily life

Positive Effects of hydrogen water on 2,4-dinitrochlorobenzene-induced atopic dermatitis in NC/Nga mice

Beneficial effects of hydrogen gas inhalation on a murine model of allergic rhinitis

Consumption of water containing a high concentration of molecular hydrogen reduces oxidative stress and disease activity in patients with rheumatoid arthritis: an open-label pilot study

Inhalation of hydrogen gas attenuates airway inflammation and oxidative stress in allergic asthmatic mice

Hydrogen gas inhalation protects against cigarette smoke-induced COPD development in mice

Hydrogen/oxygen mixed gas inhalation improves disease severity and dyspnea in patients with Coronavirus disease 2019 in a recent multicenter, openlabel clinical trial

Effects of hydrogen-rich water on depressive-like behavior in mice

Hydrogen-rich saline improves memory function in a rat model of amyloid-beta-induced Alzheimer's disease by reduction of oxidative stress

Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals

H(2) gas improves functional outcome after cardiac arrest to an extent comparable to therapeutic hypothermia in a rat model

Hydrogen inhalation during normoxic resuscitation improves neurological outcome in a rat model of cardiac arrest independently of targeted temperature management

Hydrogen gas inhalation improves delayed brain injury by alleviating early brain injury after experimental subarachnoid hemorrhage

Molecular hydrogen prevents social deficits and depression-like behaviors induced by low-intensity blast in mice

Inhalation of hydrogen gas reduces infarct size in the rat model of myocardial ischemia-reperfusion injury

H(2) mediates cardioprotection via involvements of K(ATP) channels and permeability transition pores of mitochondria in dogs. Cardiovasc Low-Flow Hydrogen Therapy

The Effects of hydrogen gas inhalation on adverse left ventricular remodeling after percutaneous coronary intervention for ST-elevated myocardial infarction-first pilot study in humans

Hydrogen-rich saline alleviates kidney fibrosis following AKI and retains klotho expression

Recent advances in studies of molecular hydrogen against sepsis

Hydrogen gas inhalation inhibits progression to the "irreversible" stage of shock after severe hemorrhage in rats

Hydrogen gas inhalation attenuates endothelial glycocalyx damage and stabilizes hemodynamics in a rat hemorrhagic shock model

Hydrogen gas in cancer treatment

Molecular hydrogen regulates gene expression by modifying the free radical chain reactiondependent generation of oxidized phospholipid mediators

Hydrogen gas inhalation alleviates oxidative stress in patients with post-cardiac arrest syndrome

Organ preservation solution containing dissolved hydrogen gas from a hydrogenabsorbing alloy canister improves function of transplanted ischemic kidneys in miniature pigs

Pharmacokinetics of a single inhalation of hydrogen gas in pigs

Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research

The authors are grateful to Suga Kato ((Japanese Molecular Hydrogen Promotion Association (JHyPA)) and Mayumi Takeda (JHyPA) for technical assistance.

The authors declare that data supporting the findings of this study are available within the article.

MS and EK receive advisory fees and research fees from Doctors Man Co., Ltd. MS receives advisory fees and research fees from Taiyo Nippon Sanso. The authors would like to declare